News BI opens second branch of digital lab in China Boehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in July this year in China.
Views & Analysis Does pharma’s future lie in China? Healthcare innovation has a long history in effective collaboration, whether that’s across academia and industry or borders.
News Vifor forges iron drug partnership with Fresenius in China Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.
Views & Analysis Nine pharma trends for 2020 Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for the industry in 2020.
Views & Analysis Nine for 2019: how did we do on our predictions, and what do... Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead.
R&D Ben Sidders on integrating causality in AI for R&D success Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face